US2006223824A1PendingUtilityA1
Serotonergic agents
Est. expiryNov 28, 2020(expired)· nominal 20-yr term from priority
A61P 43/00A61P 5/00A61P 9/00A61P 25/24A61P 3/04A61P 25/06A61P 25/22A61P 25/08A61P 25/28A61P 25/14A61P 25/18A61P 25/36A61P 25/02A61P 25/34A61P 25/32A61P 25/20A61P 25/16A61P 1/14A61P 13/10A61P 15/00A61K 31/496
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Novel piperazine derivatives are provided having the formula wherein R 1 is cyano, nitro, trifluoromethyl or halogen, or pharmaceutically acceptable acid addition salts thereof, which are useful as 5-HT 1A receptor antagonists.
Claims
exact text as granted — not AI-modified1 - 5 . (canceled)
6 . A method for treating sexual dysfunction in a patient in need thereof, the method comprising providing to the patient a therapeutically effective amount of a compound of formula (III):
wherein R 1 is cyano, nitro, trifluoromethyl or halogen, or pharmaceutically acceptable acid addition salts thereof.
7 - 12 . (canceled)
13 . The method of claim 6 , wherein the compound is (R)-4-cyano-N-{2-[4-(2,3-dihydrobenzo[1,4]dioxin-5-yl)piperazine-1-yl]-propyl}-N-pyridin-2-yl-benzamide.Join the waitlist — get patent alerts
Track US2006223824A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.